Stereotactic Ablative Radiotherapy Before Resection to Avoid Delay for Early-stage Lung Cancer or Oligometastases During the COVID-19 Pandemic
Recommended
Stereotactic Ablative Radiotherapy Before Resection to Avoid Delay for Early-stage Lung Cancer or Oligometastases During the COVID-19 Pandemic
Preliminary surgical and pathological results of the SABR-BRIDGE protocol indicate that adopting stereotactic ablative radiotherapy as a bridge to surgery results in successful and well-tolerated treatment for patients with early-stage presumed or biopsy-proven lung malignancy during operating room closures.
Access the full article to read more here.
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->